OPKO Health
OPK
#5857
Rank
HK$8.28 B
Marketcap
HK$10.43
Share price
-0.74%
Change (1 day)
-14.62%
Change (1 year)

Revenue for OPKO Health (OPK)

Revenue in 2025 (TTM): HK$5.00 Billion

According to OPKO Health 's latest financial reports the company's current revenue (TTM ) is HK$4.99 Billion. In 2024 the company made a revenue of HK$5.53 Billion a decrease over the revenue in the year 2023 that were of HK$6.74 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for OPKO Health from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$5.00 B-9.63%
2024 HK$5.53 B-17.9%
2023 HK$6.74 B-14.05%
2022 HK$7.84 B-43.3%
2021 HK$13.83 B24.36%
2020 HK$11.12 B58.41%
2019 HK$7.02 B-9.42%
2018 HK$7.75 B-0.62%
2017 HK$7.80 B-17.63%
2016 HK$9.47 B148.56%
2015 HK$3.81 B439.23%
2014 HK$0.70 B-5.57%
2013 HK$0.74 B105.27%
2012 HK$0.36 B67.8%
2011 HK$0.21 B-20.12%
2010 HK$0.27 B166.89%
2009 HK$0.10 B39.74%
2008 HK$72.94 M
2001 HK$10.39 M54.07%
2000 HK$6.74 M-34.46%
1999 HK$10.29 M2.2%
1998 HK$10.07 M333.23%
1997 HK$2.32 M0.19%
1996 HK$2.32 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
HK$717.34 B 14,251.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$341.30 B 6,728.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$110.91 B 2,119.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$130.59 B 2,512.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Alnylam Pharmaceuticals
ALNY
HK$24.98 B 399.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$373.92 B 7,381.16%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$107.15 B 2,043.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
HK$3.10 B-37.98%๐Ÿ‡บ๐Ÿ‡ธ USA